Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
about
Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and preventionDysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasisMicroRNAs as growth regulators, their function and biomarker status in colorectal cancerRegulatory Roles of Non-Coding RNAs in Colorectal CancerA Comprehensive NGS Data Analysis of Differentially Regulated miRNAs, piRNAs, lncRNAs and sn/snoRNAs in Triple Negative Breast Cancer.Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis.MicroRNA-6826 and -6875 in plasma are valuable non‑invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer.The role of cell-free DNA in predicting colorectal cancer prognosis.Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer.Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen.Epigenetic biomarkers in colorectal cancer: premises and prospects.MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancerMethods and novel technology for microRNA quantification in colorectal cancer screening.Electrochemical detection of urinary microRNAs via sulfonamide-bound antisense hybridisation.miR-183 and miR-21 expression as biomarkers of progression and survival in tongue carcinoma patients.Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.MicroRNAs as Biomarkers in Colorectal Cancer.Prognostic value of microRNAs in colorectal cancer: a meta-analysis.Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer.Overexpression of the mitochondrial chaperone tumor necrosis factor receptor-associated protein 1 is associated with the poor prognosis of patients with colorectal cancer.
P2860
Q26742027-03D9CC82-2040-4FF4-85B5-3758EBA87ED3Q26747871-58062D84-2576-4AF8-BC48-8DA6535B618FQ26775610-B8B935D3-2E6F-4E23-A143-A5E13E0EF80BQ26797350-1CE45FCE-B63A-4C66-A127-D71C230D2B02Q36331326-FFEE7135-ACD6-4E24-8396-1EA1EC752E27Q37180715-98F4935D-D9B7-46EE-BD35-672F35CD9FA8Q37707611-1B1F35E3-6FAB-4EF5-BF63-7ABD99B72F11Q38637642-F32C2F9A-0B40-4380-9B0E-8AC718FBF069Q38940594-9A0923C2-6075-4B4E-B8A6-3AEA5CB91EF9Q38943220-8E1CEE36-CA60-49E0-B90E-4255BA3ECF3EQ38992809-4DC4971F-96E5-4C88-8B7F-D6FB226F4B3BQ39090370-23F015E4-EB7A-4B94-87D2-053BB5D78D87Q42157952-08883980-B496-4C25-962B-6EF211245616Q44385577-4F1A446E-650F-46DE-A444-161EA6094F95Q45922728-7950E844-B67D-4122-8332-0768A22DFC06Q48017709-2FF07CFF-7CFF-44D2-8069-726423095389Q53112003-19C70BD4-78B4-4A56-BE7E-CF9CDB1E9F43Q55042978-789B7211-71CE-4071-872F-A7980B7E472BQ55307845-FA407B14-687B-4DDF-98F2-2B5294258F39Q55361312-6843C941-407C-4399-A3FD-9E470D7F4DF3Q55407730-4F7CEDF1-A6BC-400E-B6AF-8E037F7C85AA
P2860
Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
@ast
Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
@en
type
label
Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
@ast
Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
@en
prefLabel
Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
@ast
Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
@en
P2093
P2860
P1476
Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
@en
P2093
P2860
P304
P356
10.1080/15384047.2014.1002327
P577
2015-01-01T00:00:00Z